Trustees’ Annual Report for the period
From 25/7/2019 Period start date To 24/7/2020 Period end date
Charity name: ASSOCIATION FOR THE GLOBAL ADVANCEMENT OF ENT SURGERY AND HEAD AND NECK CANCER RESEARCH
Charity registration number: 1165453
Objectives and Activities
| SORP reference | ||
|---|---|---|
| Summary of the purposes of the charity as set out in its governing document |
Para 1.17 | The advancement of health and relief of sickness in the field of ear, nose and throat/head and neck surgery and head and neck disorders across the world in particular but not exclusively by: · Supporting the provision of awareness and screening programmes · Supporting cancer research by the provision of grants (AGA-ENT Charity Governing document - version 1.1-21/1/2016) |
| Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts. |
Para 1.17 and 1.19 |
· Supporting the provision of awareness and screening programmes · Supporting cancer research by the provision of grants |
| Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit |
Para 1.18 | Yes, the trustees have had regard. |
Additional information (optional)
You may choose to include further statements where relevant about:
SORP reference N/A Para 1.38 Policy on grant making N/A Para 1.38 Policy on social investment including program related investment
| Contribution made by volunteers |
Para 1.38 | Minor contributions, e.g. help with website and design of logo |
|---|---|---|
| Other | N/A |
Achievements and Performance
| SORP reference | ||
|---|---|---|
| Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole. |
Para 1.20 | After our BICRAA app (www.bicraa.org) has been successfully tested in India (n=1049), showing that around 30% chew betel nut (we would like to thank Prof. Kelkar and Dr. Pethe from the Deenanath Mangeshkar Hospital, Pune, for their invaluable support), the app has continued to help raise the awareness of the risks of betel nut chewing. We have now been working on a global study to extend these efforts in India and other countries. With regard to our work in Indonesia, we have continued to closely work with our partners at the Dr. Sardjito Hospital/Gadjah Mada University in Yogyakarta, Indonesia, and affiliated district general hospitals in collaboration with Prof. Bing Tan to support the local Nasopharyngeal Cancer (NPC) awareness and early detection programme and to support research and publications of results. The company Storz has continued to support our programme and in 2019 we were able to award four fellowship grants to young surgeons, sponsored by a donation by the company Storz, allowing them travel to low and middle income countries and helping with the local charitable work. |
| Additional information (optional) You may choose to include further statements |
where relevant about: | |
| Achievements against objectives set |
Para 1.41 | As above. Taking the above work into account AGA-ENT has made contributions to the advancement of health and relief of sickness in the field of ear, nose and throat/head and neck surgery and head and neck disorders in low and middle income countries. |
| Performance of fundraising activities against objectives set |
Para 1.41 | Good progress. Substantive funding will be sought once the preliminary data are published. |
| Investment performance against objectives |
Para 1.41 | N/A |
NIA Other
Financial Review
| Financial Review | ||
|---|---|---|
| Review of the charity’s financial position at the end of the period |
Para 1.21 | 24/7/2020 |
| Statement explaining the policy for holding reserves stating why they are held |
Para 1.22 | Year on year the charity hopes to increase the reserves to in line with 2 years possible commitments |
| Amount of reserves held | Para 1.22 | £1000 |
| Reasons for holding zero reserves |
Para 1.22 | N/A |
| Details of fund materially in deficit |
Para 1.24 | N/A |
| Explanation of any uncertainties about the charity continuing as a going concern |
Para 1.23 | N/A |
| Additional information (optional) You may choose to include further statements |
Additional information (optional) You may choose to include further statements |
where relevant about: |
|---|---|---|
| The charity’s principal sources of funds (including any fundraising) |
Para 1.47 | Donations by private donors and donated equipment. |
| Investment policy and objectives including any social investment policy adopted |
Para 1.46 | N/A |
| A description of the principal risks facing the charity |
Para 1.46 | At present funds are sufficient to achieve the aims set, but more funding is needed to be sought to continue to expand our work. Ensuring the ongoing income is the most important risk we manage. |
| Other | N/A |
Structure, Governance and Management
| Description of charity’s trusts: |
||
|---|---|---|
| Type of governing document (trust deed, royal charter) |
Para 1.25 | Constitution of the Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research (AGA- ENT), a Charitable Incorporated Organisation with voting members other than its charity trustees Date of constitution (last amended): 21/01/2016 (AGA-ENT Charity Governing document - version 1.1 - 21/1/2016) |
| How is the charity constituted? (e.g unincorporated association, CIO) |
Para 1.25 | Charitable Incorporated Organisation |
| Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees |
Para 1.25 | The current trustees volunteered to take on these roles with the support of all founding members and fulfil these roles in line with the duties outlined in the AGA-ENT Charity Governing document - version 1.1 - 21/1/2016 |
Additional information (optional)
| Additional information (optional) | Additional information (optional) | |
|---|---|---|
| You may choose to include further statements | where relevant about: | |
| Policies and procedures adopted for the induction and training of trustees |
Para 1.51 | All duties outlined in the AGA-ENT Charity Governing document - version 1.1 - 21/1/2016 and discussed during regular Trustees’ meetings. |
| The charity’s organisational structure and any wider network with which the charity works |
Para 1.51 | Charitable Incorporated Organisation with voting members other than its charity trustees |
| Relationship with any related parties |
Para 1.51 | Collaborators and partners globally who help to achieve the outlined objectives, usually within the network of Founding Members. |
| Other | N/A |
Reference and Administrative details
Charity name Association for the Global Advancement of ENT Surgery and - Head and Neck Cancer Research (AGA ENT) Other name the charity uses AGA-ENT Registered charity number 1165453
| Charity’s principal address | Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research (AGA-ENT), Health Foundry, Canterbury House, 1 Royal Street, London, SE1 7LL |
|---|---|
Names of the charity trustees who manage the charity
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Trustee name | Office (if any) | Dates acted if not for whole year |
Name of person (or body) entitled to appoint trustee (if any) |
|---|---|---|---|---|
| Paul O’Flynn | 5/2/2016 – current date | Membershipbody | ||
| Matt Lechner | 5/2/2016 – current date | Membershipbody | ||
| Valerie J. Lund | 5/2/2016 – current date | Membershipbody | ||
| Francis M. Vaz | 5/2/2016 – current date | Membershipbody | ||
| Tim Tang | 5/2/2016 - 4/6/2017 | Membershipbody | ||
– Corporate trustees names of the directors at the date the report was approved
Director name N/A
Name of trustees holding title to property belonging to the charity
| Trustee name | Dates acted if not for whole year | |
|---|---|---|
| N/A | ||
Funds held as custodian trustees on behalf of others
Description of the assets None held in this capacity
Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets
Additional information (optional)
Names and addresses of advisers (Optional information)
| Names and addresses of advisers (Optional information) | Names and addresses of advisers (Optional information) | Names and addresses of advisers (Optional information) |
|---|---|---|
| Type of adviser Name Address |
||
| N/A | ||
| Name of chief executive or names of senior staff members (Optional information) | ||
| N/A |
Exemptions from disclosure
Reason for non-disclosure of key personnel details
The charity is too small still to employ personnel
Other optional information
N/A
Declarations
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
| Signature(s) Full name(s) Position (eg Secretary, Chair, etc) Date |
||
|---|---|---|
| Matt Lechner | ||
Trustee |
||
| 20/05/2021 | ||
| 20/05/2021 |
Association for the Global Advancement of ENT Surgery 1165453 and Head and Neck Cancer Research Receipts and payments accounts CC16a For the period 25/07/2019 To 24/07/2020 from
| Section A Receipts and payments | Section A Receipts and payments | |||||
|---|---|---|---|---|---|---|
| A1 Receipts | Unrestricted funds to the nearest £ 8,500 4,000 - - - - - - 12,500 - - - 12,500 421 634 4,000 5,000 258 132 960 137 - 41 - - 11,584 - - - 11,584 916 - 3,212 4,128 |
Restricted funds to the nearest £ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Endowment funds to the nearest £ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Total funds to the nearest £ 8,500 4,000 - - - - - - 12,500 - - - 12,500 421 634 4,000 5,000 258 132 960 137 - 41 - - 11,584 - - - 11,584 916 |
Last year to the nearest £ |
|
| Donations | 8,500 | 6,583 | ||||
| FellowshipFunding | 4,000 | - | ||||
| - | - | |||||
| - | - | |||||
| - | - | |||||
| - | - | |||||
| - | - | |||||
| - | - | |||||
| Sub total(Gross income for AR) |
12,500 | 6,583 | ||||
| A2 Asset and investment sales, (see table). |
||||||
| - | ||||||
| - | - | |||||
| Sub total | - | - | ||||
| Total receipts A3 Payments |
||||||
| 6,583 | ||||||
| Fundraisingcosts | 421 | - | ||||
| Web hosting | 634 | 24 | ||||
| FellowshipAwards | 4,000 | 4,000 | ||||
| Research costs | 5,000 | - | ||||
| Conference costs | 258 | - | ||||
| Printing, postage and stationery | 132 | - | ||||
| Office costs | 960 | - | ||||
| Sundryexpenses | 137 | 292 | ||||
| - | - | |||||
| Bank charges | 41 | 80 | ||||
| - | - | |||||
| - | - | |||||
| **Sub total ** | 11,584 | 4,396 | ||||
| A4 Asset and investment purchases, (see table) |
||||||
| - | ||||||
| - | ||||||
| **Sub total ** | - | - | ||||
| Total payments Net of receipts/(payments) A5 Transfers between funds A6 Cash funds last year end Cash funds this year end |
||||||
| 4,396 | ||||||
| 916 | - | - | 916 |
2,187 | ||
| - | - | - | - | - | ||
| 3,212 | - | - | 3,212 | 1,025 | ||
| 4,128 | - | - | 4,128 | 3,212 |
1
Section B Statement of assets and liabilities at the end of the period
| Categories Signed by one or two trustees on behalf of all the trustees B5 Liabilities B4 Assets retained for the charity’s own use B3 Investment assets B2 Other monetary assets B1 Cash funds |
Signature Details Details Details Total cash funds (agree balances with receipts and payments account(s)) Details Details Bank accounts 2 |
Unrestricted funds Restricted funds to nearest £ to nearest £ 4,128 - - - - - 4,128 - OK OK Unrestricted funds Restricted funds to nearest £ to nearest £ - - - - - - - - - - - - Fund to which asset belongs Cost (optional) - - - - - Fund to which asset belongs Cost (optional) - - - - - - - - - Fund to which liability relates Amount due (optional) - - - - Print Name M Lechner |
Endowment funds to nearest £ |
|---|---|---|---|
| - | |||
| - | |||
| - | |||
| - | |||
| OK | |||
| Endowment funds to nearest £ |
|||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| Current value (optional) |
|||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| Current value (optional) |
|||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| When due (optional) |
|||
| Date of approval |
|||
| 20/05/2021 | |||